SpringWorks Therapeutics Inc (SWTX)

35.63 +0.85 (+2.44%) USD  |  NASDAQ  |  Dec 20, 16:00
35.66 +0.03 (+0.08%) After-Hours: 20:00
More

SpringWorks Therapeutics Max Drawdown (5Y): 80.38% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for SWTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Vertex Pharmaceuticals Inc 41.60%
PTC Therapeutics Inc 73.78%
Blueprint Medicines Corp 69.50%
Edgewise Therapeutics Inc --
NovaBay Pharmaceuticals Inc 99.98%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) -1.218
Beta (5Y) 0.8620
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 61.85%
Historical Sharpe Ratio (5Y) 0.1665
Historical Sortino (5Y) 0.3019
Monthly Value at Risk (VaR) 5% (5Y Lookback) 22.78%